M·CAM, Inc. releases Patently Obvious™ on Abbott Labs’ U.S. Patent No. 6,175,752

Date:  Thu, 2010-11-25

M·CAM, Inc. releases Patently Obvious&#!53; on Abbott Labs’ U.S. Patent No. 6,175,752

CHARLOTTESVILLE, VA – November 23, 2010 –– M·CAM, Inc. released its Patently Obvious™ report today on the patent holdings of Abbott Labs highlighted in Abbott Diabetes Care, Inc., v. Dexcom, Inc., Civil Action No. 06–514–GMS. On August 11, 2005, Abbott Diabetes Care filed a lawsuit against DexCom over their continuous glucose monitoring system, SEVEN PLUS, claiming that it infringed on four of their patents. Soon after being served with the lawsuit, DexCom put in a request to the United States Patent and Trademark Office (USPTO) for reexamination of the four Abbott patents asserted in the lawsuit, a request that was granted in March of 2006.

The question stands: are Abbott Diabetes Care’s infringement claims against DexCom valid, or will the outcome of the patent reexamination process undermine their role as a market leader? Using the M·CAM DOORS™ software platform, the innovation space surrounding the asserted patents was examined in order to understand their strength and defensibility in the face of prior and concurrent art innovations.

M·CAM’s Patently Obvious™ is a weekly report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM, Inc. is a global, full–service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards–based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious™ report on Abbott Labs can be found HERE